The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
p53-A natural cancer killer: Structural insights and therapeutic concepts
Abstract
Every single day, the DNA of each cell in the human body is mutated thousands of times, even in absence of oncogenes or extreme radiation. Many of these mutations could lead to cancer and, finally, death. To fight this, multicellular organisms have evolved an efficient control system with the tumor‐suppressor protein p53 as the central element. An intact p53 network ensures that DNA damage is detected early on. The importance of p53 for preventing cancer is highlighted by the fact that p53 is inactivated in more than 50 % of all human tumors. Thus, for good reason, p53 is one of the most intensively studied proteins. Despite the great effort that has been made to characterize this protein, the complex function and the structural properties of p53 are still only partially known. This review highlights basic concepts and recent progress in understanding the structure and regulation of p53, focusing on emerging new mechanistic and therapeutic concepts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 is a homotetramer, with folded tetramerization and core domains that are linked together and flanked by intrinsically disordered (or natively unfolded) domains at the N and C termini (1, 2).”
From Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain (2008) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Self-citationCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Intrinsically disordered protein
Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., et al. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00138-8 · Cited by 2,272
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Research works printed but not linked: 286
- Chang C., 1979, J. Virol., 31, 463, 10.1128/jvi.31.2.463-471.1979 · DOI
- 10.1038/278261a0 · DOI · Paper page
- 10.1016/0092-8674(79)90293-9 · DOI · Paper page
- 10.1002/ijc.2910570102 · DOI · Paper page
- 10.1038/35042675 · DOI · Paper page
- 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- 10.1093/emboj/17.7.1847 · DOI · Paper page
- 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H · doi:10.1002/(sici)1098-1004(1999)14:1<1::aid-humu1>3.0.co;2-h
- Jin S., 2001, J. Cell Sci., 114, 4139, 10.1242/jcs.114.23.4139 · DOI · Paper page
- 10.1038/35077213 · DOI · Paper page
- 10.1128/MCB.4.9.1689 · DOI · Paper page
- 10.1007/BF01534845 · doi:10.1007/bf01534845
- 10.1038/319783a0 · DOI · Paper page
- 10.1073/pnas.85.14.5146 · DOI
- Soussi T., 1990, Oncogene, 5, 945
- 10.1007/978-3-642-80481-6_1 · DOI
- 10.1038/sj.onc.1201263 · DOI · Paper page
- 10.1073/pnas.93.26.15335 · DOI · Paper page
- 10.1093/emboj/17.16.4668 · DOI · Paper page
- 10.1126/science.2144363 · DOI · Paper page
- 10.1073/pnas.92.11.5154 · DOI · Paper page
- 10.1126/science.7809597 · DOI · Paper page
- 10.1038/sj.onc.1203312 · DOI
- 10.1073/pnas.96.26.14801 · DOI
- 10.1128/jvi.69.3.1851-1859.1995 · DOI · Paper page
- 10.1126/science.281.5383.1674 · DOI · Paper page
- 10.1006/jmbi.2001.5082 · DOI
- 10.1016/S0022-2836(02)00848-3 · DOI · Paper page
- 10.1016/j.jmb.2003.08.008 · DOI · Paper page
- 10.1074/jbc.M003107200 · DOI · Paper page
- 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7 · DOI · Paper page
- 10.1074/jbc.M508149200 · DOI
- 10.1101/gad.7.12b.2565 · DOI · Paper page
- 10.1101/gad.7.12b.2556 · DOI · Paper page
- 10.1016/0092-8674(92)90562-Q · DOI · Paper page
- 10.1128/MCB.14.8.5182 · DOI · Paper page
- Hainaut P., 1994, Oncogene, 9, 299
- 10.1021/bi00016a002 · DOI
- 10.1093/emboj/17.10.2748 · DOI
- 10.1038/5880 · DOI
- 10.1038/nsb0495-321 · DOI · Paper page
- 10.1038/nsb1294-877 · DOI · Paper page
- 10.1126/science.7878469 · DOI · Paper page
- 10.1016/j.jmb.2004.06.071 · DOI · Paper page
- 10.1006/jmbi.2001.4450 · DOI
- 10.1038/nsb0901-730 · DOI
- 10.1074/jbc.M107516200 · DOI · Paper page
- 10.1101/SQB.1994.059.01.024 · DOI
- 10.1016/0092-8674(95)90165-5 · DOI · Paper page
- 10.1128/MCB.17.11.6255 · DOI
- 10.1016/j.jmb.2004.07.042 · DOI · Paper page
- 10.1038/sj.onc.1203285 · DOI · Paper page
- 10.1016/j.str.2005.01.020 · DOI · Paper page
- 10.1128/MCB.4.9.1689 · DOI · Paper page
- 10.1074/jbc.271.7.3917 · DOI
- 10.1006/jmbi.1997.1507 · DOI
- 10.1074/jbc.M407687200 · DOI
- 10.1074/jbc.M407601200 · DOI
- 10.1021/bi011736r · DOI
- 10.1021/bi970759w · DOI · Paper page
- 10.1016/j.febslet.2004.07.014 · DOI
- 10.1073/pnas.132393699 · DOI
- 10.1074/jbc.M102817200 · DOI · Paper page
- 10.1074/jbc.M206697200 · DOI
- 10.1016/S0092-8674(00)80540-1 · DOI · Paper page
- 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
- Moll U. M., 2004, Mol. Cancer Res., 2, 371, 10.1158/1541-7786.371.2.7 · DOI · Paper page
- 10.1016/j.tibs.2003.10.004 · DOI · Paper page
- 10.1038/nm0798-747 · DOI · Paper page
- 10.1016/S0168-9525(02)02595-7 · DOI · Paper page
- 10.1093/emboj/18.16.4438 · DOI · Paper page
- 10.1107/S0907444901002529 · DOI
- 10.1002/pro.5560060128 · DOI · Paper page
- 10.1074/jbc.M307846200 · DOI
- Lu H., 1999, FASEB J., 13, 1538
- 10.1038/sj.onc.1204427 · DOI · Paper page
- 10.1023/A:1024044805720 · DOI
- 10.1016/S0006-2952(03)00511-2 · DOI
- 10.4161/cbt.4.4.1619 · DOI
- 10.1016/j.ccr.2005.02.019 · DOI · Paper page
- 10.1038/416560a · DOI · Paper page
- 10.1016/S0092-8674(00)80627-3 · DOI · Paper page
- 10.1126/science.1065486 · DOI · Paper page
- 10.1073/pnas.97.13.7301 · DOI · Paper page
- 10.1016/S0092-8674(00)80626-1 · DOI · Paper page
- 10.1016/S0960-9822(01)00534-6 · DOI · Paper page
- 10.1038/35094077 · DOI · Paper page
- 10.1073/pnas.96.5.1875 · DOI
- 10.1073/pnas.92.19.8591 · DOI
- 10.1016/j.jmb.2005.03.014 · DOI · Paper page
- 10.1093/emboj/18.3.763 · DOI
- 10.1074/jbc.M103801200 · DOI
- 10.1016/S0022-2836(02)00326-1 · DOI · Paper page
- 10.1074/jbc.M011644200 · DOI
- 10.1002/ange.200501887 · DOI
- 10.1002/anie.200501887 · DOI
- 10.1101/SQB.1994.059.01.025 · DOI
- Arrowsmith C. H., 1996, Oncogene, 12, 1379
- 10.1093/protein/14.4.233 · DOI
- 10.1073/pnas.0500215102 · DOI
- 10.1073/pnas.90.8.3319 · DOI · Paper page
- 10.1074/jbc.M603634200 · DOI · Paper page
- Wang X., 1995, Cancer Epidemiol. Biomarkers Prev., 4, 543
- 10.1002/humu.10185 · DOI · Paper page
- 10.1038/sj.onc.1204468 · DOI
- 10.1074/jbc.M507611200 · DOI · Paper page
- 10.1126/science.1905840 · DOI · Paper page
- Hollstein M., 1994, Nucleic Acids Res., 22, 3551
- 10.1093/nar/25.1.151 · DOI · Paper page
- 10.1128/MCB.12.6.2866 · DOI · Paper page
- Sigal A., 2000, Cancer Res., 60, 6788
- 10.1093/nar/gki252 · DOI
- 10.1007/s000180050271 · DOI
- 10.1073/pnas.92.12.5729 · DOI
- 10.1016/S0968-0004(00)88954-9 · DOI
- 10.1038/sj.onc.1203434 · DOI · Paper page
- 10.1038/sj.onc.1202041 · DOI · Paper page
- 10.1016/S0955-0674(03)00003-6 · DOI · Paper page
- 10.1046/j.1432-1327.2001.02225.x · DOI · Paper page
- 10.1006/jmbi.1996.0560 · DOI
- 10.4161/cc.4.4.1598 · DOI · Paper page
- 10.1016/S0960-9822(00)00439-5 · DOI · Paper page
- 10.1038/sj.onc.1202480 · DOI · Paper page
- 10.1074/jbc.M410233200 · DOI · Paper page
- 10.1038/42972 · DOI · Paper page
- 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- 10.1046/j.1432-1327.2001.02226.x · DOI · Paper page
- 10.1016/S0092-8674(01)00619-5 · DOI · Paper page
- 10.1016/S0092-8674(01)00524-4 · DOI · Paper page
- 10.1016/S0092-8674(01)00527-X · DOI · Paper page
- 10.1002/0470862637.ch14 · DOI
- 10.1038/nrm731 · DOI · Paper page
- 10.1074/jbc.275.12.8945 · DOI · Paper page
- 10.1038/35096061 · DOI · Paper page
- 10.1016/S1357-4310(98)01260-X · DOI
- 10.1038/nature737 · DOI · Paper page
- 10.1016/j.cell.2005.03.037 · DOI · Paper page
- 10.1038/nature02514 · DOI · Paper page
- 10.1016/S0092-8674(03)00193-4 · DOI · Paper page
- 10.1016/j.cell.2005.06.018 · DOI
- 10.1093/emboj/18.22.6455 · DOI · Paper page
- 10.1093/emboj/18.22.6462 · DOI · Paper page
- 10.4161/cc.1.4.131 · DOI
- 10.1016/j.cell.2004.06.015 · DOI
- 10.1016/j.cell.2004.06.016 · DOI · Paper page
- Shaw P., 1996, Oncogene, 12, 921
- 10.1002/(SICI)1097-4644(199607)62:1<90::AID-JCB10>3.0.CO;2-J · doi:10.1002/(sici)1097-4644(199607)62:1<90::aid-jcb10>3.0.co;2-j
- 10.1073/pnas.0308762101 · DOI · Paper page
- 10.1038/nrc864 · DOI · Paper page
- 10.1093/nar/26.15.3453 · DOI · Paper page
- 10.1007/BF03402141 · DOI · Paper page
- 10.1007/BF03401678 · DOI
- Picksley S. M., 1994, Oncogene, 9, 2523
- 10.1128/MCB.13.7.4107 · DOI · Paper page
- 10.1073/pnas.96.26.14801 · DOI
- 10.1016/S0022-2836(02)00852-5 · DOI · Paper page
- 10.1016/j.jmb.2003.11.051 · DOI
- 10.1073/pnas.0334477100 · DOI
- 10.1093/embo-reports/kve227 · DOI · Paper page
- 10.1016/j.bbrc.2005.03.151 · DOI · Paper page
- 10.1016/j.jmb.2005.05.010 · DOI
- 10.1023/B:JNMR.0000048856.84603.9b · DOI
- 10.1007/PL00012484 · doi:10.1007/pl00012484
- 10.1002/1521-3757(20020402)114:7<1142::AID-ANGE1142>3.0.CO;2-T · DOI
- 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9 · DOI · Paper page
- 10.1146/annurev.cb.09.110193.003125 · DOI · Paper page
- 10.1016/S0092-8674(00)80928-9 · DOI · Paper page
- 10.1016/j.molcel.2005.09.028 · DOI · Paper page
- 10.1126/science.2188360 · DOI · Paper page
- 10.1038/370111a0 · DOI · Paper page
- 10.1146/annurev.bi.62.070193.002025 · DOI · Paper page
- 10.1093/emboj/18.24.6934 · DOI · Paper page
- 10.1007/s10254-003-0021-1 · DOI · Paper page
- Hupp T. R., 2000, Biochem. J., 1, 10.1042/bj3520001 · DOI
- 10.1093/emboj/20.22.6297 · DOI · Paper page
- 10.1016/0014-5793(94)01417-Y · DOI
- 10.1093/emboj/20.17.4634 · DOI · Paper page
- 10.1074/jbc.M100200200 · DOI
- 10.1046/j.1365-2184.2000.00189.x · DOI · Paper page
- 10.1074/jbc.274.39.27474 · DOI
- 10.1128/MCB.16.3.1126 · DOI · Paper page
- 10.1128/MCB.4.12.2802 · DOI · Paper page
- 10.1016/S0021-9258(18)33376-3 · DOI · Paper page
- 10.1074/jbc.272.30.18608 · DOI
- 10.1073/pnas.93.16.8379 · DOI · Paper page
- 10.1074/jbc.271.25.15084 · DOI
- 10.1128/MCB.18.3.1517 · DOI · Paper page
- 10.1038/sj.onc.1202978 · DOI
- 10.1016/S0014-5793(99)00505-0 · DOI
- 10.1093/emboj/20.4.914 · DOI · Paper page
- 10.1074/jbc.275.21.16202 · DOI · Paper page
- 10.1002/path.1704 · DOI
- 10.1016/j.mrfmmm.2004.08.022 · DOI
- 10.1016/j.ceb.2005.09.007 · DOI · Paper page
- 10.1378/chest.125.5_suppl.83S-a · DOI
- 10.1093/emboj/cdf595 · DOI · Paper page
- Kastan M. B., 1991, Cancer Res., 51, 6304
- 10.1101/gad.8.21.2540 · DOI · Paper page
- Linke S. P., 1997, Cancer Res., 57, 1171
- 10.1038/35106045 · DOI · Paper page
200 of 286 shown
Cited by
Galliford, C. V., & Scheidt, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701342 · Cited by 2,429
Natürliche Pyrrolidinylspirooxindole als Vorlagen für die Entwicklung medizinischer Wirkstoffe
Galliford, C. V., & Scheidt, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200701342 · Cited by 524
Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain
Wells, M., Tidow, H., Rutherford, T. J., Markwick, P., Jensen, M. R., Mylonas, E., Svergun, D. I., Blackledge, M., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801353105 · Cited by 434
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
The Tumor Suppressor p53: From Structures to Drug Discovery
Joerger, A. C., & Fersht, A. R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000919 · Cited by 357
β-Hairpin Peptidomimetics: Design, Structures and Biological Activities
Robinson, J. A. (2008) · Accounts of Chemical Research · doi:10.1021/ar700259k · Cited by 321
The architecture of functional modules in the Hsp90 co‐chaperone Sti1/Hop
Schmid, A. B., Lagleder, S., Gräwert, M. A., Röhl, A., Hagn, F., Wandinger, S. K., Cox, M. B., Demmer, O., Richter, K., Groll, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.472 · Cited by 229
Self-citationStructural analysis of the interaction between Hsp90 and the tumor suppressor protein p53
Hagn, F., Lagleder, S., Retzlaff, M., Rohrberg, J., Demmer, O., Richter, K., Buchner, J., & Kessler, H. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2114 · Cited by 127
“An Hsp90 client of high interest is the tumor suppressor p53 (ref”
BackgroundSelf-citationLiao, Z.-Y., Chen, J.-L., Xiao, M.-H., Sun, Y., Zhao, Y.-X., Pu, D., Lv, A.-K., Wang, M.-L., Zhou, J., Zhu, S.-Y., et al. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.032 · Cited by 102
“P53 is a tumour suppressor gene, with> 50% of p53 mutations detected in all malignancies (Romer et al., 2006). p53-encoded proteins are transcription factors that control cell cycle initiation.”
Metadata
- Authors
- Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2006-09-29
- Volume
- 45
- Issue
- 39
- Pages
- 6440-6460
- ISSN
- 1433-7851
- 1521-3773
- Cited by
- 93
- References
- 45
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.